The full sequencing of GBA1 warrants the identification of rare or population-specific variants, shedding light on the pathophysiology of effects of GBA1 in PD and helping to recruit more eligible patients for GBA1-targeted trials5. This evidence concerns the gene GBA1 and Parkinson disease.